Within two days, the CEO and CFO of Lian Biotech (LIAN. US) left one after another.
On December 19th local time in the United States, Liantuo Biotechnology announced on its official website that its CEO, Wang Yizhe, has resigned from the company in search of other opportunities. Adam Stone, Chief Investment Officer of Perceive Advisors, a US biopharmaceutical investment fund, and a member of the Board of Directors of Liantuo Biotechnology, will serve as interim C ...
阅读全文